Related Experiment Video
Updated: Aug 6, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
Published on: October 25, 2024
Lysophosphatidic acid enhances antimycobacterial activity both in vitro and ex vivo
1Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica-00133, Rome, Italy.
Abstract:
Lysophosphatidic acid (LPA) is a polar lipid metabolite which is involved in a wide range of biological processes, including cell proliferation and migration, wound healing, and increase of endothelial permeability. The present study reports evidences showing that LPA is able to enhance the antimicrobial activity of human macrophages and of bronchoalveolar lavage cells from tuberculosis patients leading to intracellular growth control of Mycobacterium tuberculosis. Such antimicrobial activity is mediated by the activation of phospholipase D which in turn induces acidification of M. tuberculosis containing phagosomes and is associated with the enhanced expression of Cathepsin D. These results suggest the possible protective role of this lysophospholipid in the activation of innate antimycobacterial response.
Insights
Lysophosphatidic acid (LPA) enhances macrophage antimicrobial activity against Mycobacterium tuberculosis. This lipid metabolite boosts the innate immune response, aiding in controlling intracellular bacterial growth.
Area of Science:
- Immunology
- Lipid Metabolism
- Microbiology
Background:
- Lysophosphatidic acid (LPA) is a bioactive lipid mediator involved in numerous physiological processes.
- Tuberculosis (TB) remains a significant global health challenge, necessitating novel therapeutic strategies.
- Understanding host-pathogen interactions in TB is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the effect of LPA on the antimicrobial activity of human immune cells against Mycobacterium tuberculosis.
- To elucidate the mechanisms underlying LPA-mediated control of intracellular M. tuberculosis growth.
Main Methods:
- Human macrophages and bronchoalveolar lavage cells from TB patients were treated with LPA.
- Intracellular growth of M. tuberculosis within these cells was quantified.
- The role of phospholipase D, phagosome acidification, and Cathepsin D expression was assessed.
Main Results:
- LPA significantly enhanced the antimicrobial activity of macrophages and bronchoalveolar lavage cells.
- LPA treatment led to reduced intracellular growth of M. tuberculosis.
- The observed antimicrobial effect was mediated by phospholipase D activation, leading to phagosome acidification and increased Cathepsin D expression.
Conclusions:
- LPA enhances the innate antimycobacterial immune response.
- LPA may represent a potential therapeutic agent for boosting host defense against tuberculosis.
- Targeting LPA signaling could be a promising strategy for TB treatment.
Related Concept Videos
Antimicrobial Effectiveness
Antifungal Agents
Inhibitors of Gram-positive Cell Wall Synthesis
Gene Regulation in Microbial Communities: Quorum Sensing
